Abstract: The present invention relates to pyrazolopyridine derivatives, which are useful as medicaments, pharmaceutical compositions comprising one or more of the pyrazolopyridine derivatives, and the use of one or more of the pyrazolopyridine derivatives in methods for treating and/or preventing a disease caused or mediated by a parasite of the family Trypanosomatidae.
Type:
Grant
Filed:
September 8, 2015
Date of Patent:
December 12, 2017
Assignee:
HELMHOLTZ ZENTRUM MUENCHEN—DEUTSCHES FORSCHUNGZENTRUM FUER GESUNDHEIT UN
Inventors:
Michael Sattler, Grzegorz Popowicz, Maciej Dawidowski, Leonidas Emmanouilidis, Ralf Erdmann, Wolfgang Schliebs, Vishal Kalel